Romania’s Biofarm becomes part of Polish Polpharma

Romanian pharmaceuticals producer Biofarm (BVB: BIO) announced that it is joining the Polpharma Group, a new stage of joint development, in which "the solid market position, brand awareness and team experience will be supported by the scale, resources and expertise of one of the main players in the pharmaceutical industry in Central and Eastern Europe."

The operation by which the Polish company Zakłady Farmaceutyczne Polpharma takes over Biofarm was recently processed on the Bucharest Stock Exchange, Profit.ro reported. Polpharma carried out a public buyout offer, after the majority shareholder Longshield Investment Group (LONG), with a 51.67% stake in the shares, and Lion Capital (LION), with a 36.74% stake in the securities, had committed to sell.